Highlights

[CARING] YoY Annualized Quarter Result on 2015-11-30 [#2]

Stock [CARING]: CARING PHARMACY GROUP BHD
Announcement Date 27-Jan-2016
Admission Sponsor -
Sponsor -
Financial Year 31-May-2016
Quarter 30-Nov-2015  [#2]
Profit Trend QoQ -     43.96%    YoY -     10.97%
Quarter Report


View:


Show?  YoY % Horiz. %

Annualized Quarter Result
30/11/18 30/11/17 30/11/16 30/11/15 30/11/14 30/11/13 30/11/12 CAGR
Revenue 564,486 497,390 449,600 381,682 354,810 335,456 0 -
  YoY % 13.49% 10.63% 17.79% 7.57% 5.77% 0.00% -
  Horiz. % 168.27% 148.27% 134.03% 113.78% 105.77% 100.00% -
PBT 32,468 26,214 13,324 8,468 8,056 21,666 0 -
  YoY % 23.86% 96.74% 57.35% 5.11% -62.82% 0.00% -
  Horiz. % 149.86% 120.99% 61.50% 39.08% 37.18% 100.00% -
Tax -8,766 -7,078 -3,730 -2,374 -2,256 -5,416 0 -
  YoY % -23.85% -89.76% -57.12% -5.23% 58.35% 0.00% -
  Horiz. % 161.85% 130.69% 68.87% 43.83% 41.65% 100.00% -
NP 23,702 19,136 9,594 6,094 5,800 16,250 0 -
  YoY % 23.86% 99.46% 57.43% 5.07% -64.31% 0.00% -
  Horiz. % 145.86% 117.76% 59.04% 37.50% 35.69% 100.00% -
NP to SH 19,656 15,056 6,970 5,868 5,288 14,444 0 -
  YoY % 30.55% 116.01% 18.78% 10.97% -63.39% 0.00% -
  Horiz. % 136.08% 104.24% 48.26% 40.63% 36.61% 100.00% -
Tax Rate 27.00 % 27.00 % 27.99 % 28.03 % 28.00 % 25.00 % - % -
  YoY % 0.00% -3.54% -0.14% 0.11% 12.00% 0.00% -
  Horiz. % 108.00% 108.00% 111.96% 112.12% 112.00% 100.00% -
Total Cost 540,784 478,254 440,006 375,588 349,010 319,206 0 -
  YoY % 13.07% 8.69% 17.15% 7.62% 9.34% 0.00% -
  Horiz. % 169.42% 149.83% 137.84% 117.66% 109.34% 100.00% -
Net Worth 141,509 132,800 121,915 119,738 117,561 108,853 - -
  YoY % 6.56% 8.93% 1.82% 1.85% 8.00% 0.00% -
  Horiz. % 130.00% 122.00% 112.00% 110.00% 108.00% 100.00% -
Dividend
30/11/18 30/11/17 30/11/16 30/11/15 30/11/14 30/11/13 30/11/12 CAGR
Div 21,770 13,062 6,531 - - - - -
  YoY % 66.67% 100.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 333.33% 200.00% 100.00% - - - -
Div Payout % 110.76 % 86.76 % 93.70 % - % - % - % - % -
  YoY % 27.66% -7.41% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 118.21% 92.59% 100.00% - - - -
Equity
30/11/18 30/11/17 30/11/16 30/11/15 30/11/14 30/11/13 30/11/12 CAGR
Net Worth 141,509 132,800 121,915 119,738 117,561 108,853 - -
  YoY % 6.56% 8.93% 1.82% 1.85% 8.00% 0.00% -
  Horiz. % 130.00% 122.00% 112.00% 110.00% 108.00% 100.00% -
NOSH 217,706 217,706 217,706 217,706 217,706 217,706 - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% -
Ratio Analysis
30/11/18 30/11/17 30/11/16 30/11/15 30/11/14 30/11/13 30/11/12 CAGR
NP Margin 4.20 % 3.85 % 2.13 % 1.60 % 1.63 % 4.84 % - % -
  YoY % 9.09% 80.75% 33.13% -1.84% -66.32% 0.00% -
  Horiz. % 86.78% 79.55% 44.01% 33.06% 33.68% 100.00% -
ROE 13.89 % 11.34 % 5.72 % 4.90 % 4.50 % 13.27 % - % -
  YoY % 22.49% 98.25% 16.73% 8.89% -66.09% 0.00% -
  Horiz. % 104.67% 85.46% 43.10% 36.93% 33.91% 100.00% -
Per Share
30/11/18 30/11/17 30/11/16 30/11/15 30/11/14 30/11/13 30/11/12 CAGR
RPS 259.29 228.47 206.52 175.32 162.98 154.09 - -
  YoY % 13.49% 10.63% 17.80% 7.57% 5.77% 0.00% -
  Horiz. % 168.27% 148.27% 134.03% 113.78% 105.77% 100.00% -
EPS 9.02 6.92 3.20 2.70 2.42 6.64 0.00 -
  YoY % 30.35% 116.25% 18.52% 11.57% -63.55% 0.00% -
  Horiz. % 135.84% 104.22% 48.19% 40.66% 36.45% 100.00% -
DPS 10.00 6.00 3.00 0.00 0.00 0.00 0.00 -
  YoY % 66.67% 100.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 333.33% 200.00% 100.00% - - - -
NAPS 0.6500 0.6100 0.5600 0.5500 0.5400 0.5000 - -
  YoY % 6.56% 8.93% 1.82% 1.85% 8.00% 0.00% -
  Horiz. % 130.00% 122.00% 112.00% 110.00% 108.00% 100.00% -
Adjusted Per Share Value based on latest NOSH - 217,706
30/11/18 30/11/17 30/11/16 30/11/15 30/11/14 30/11/13 30/11/12 CAGR
RPS 259.29 228.47 206.52 175.32 162.98 154.09 - -
  YoY % 13.49% 10.63% 17.80% 7.57% 5.77% 0.00% -
  Horiz. % 168.27% 148.27% 134.03% 113.78% 105.77% 100.00% -
EPS 9.02 6.92 3.20 2.70 2.42 6.64 0.00 -
  YoY % 30.35% 116.25% 18.52% 11.57% -63.55% 0.00% -
  Horiz. % 135.84% 104.22% 48.19% 40.66% 36.45% 100.00% -
DPS 10.00 6.00 3.00 0.00 0.00 0.00 0.00 -
  YoY % 66.67% 100.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 333.33% 200.00% 100.00% - - - -
NAPS 0.6500 0.6100 0.5600 0.5500 0.5400 0.5000 - -
  YoY % 6.56% 8.93% 1.82% 1.85% 8.00% 0.00% -
  Horiz. % 130.00% 122.00% 112.00% 110.00% 108.00% 100.00% -
Price Multiplier on Financial Quarter End Date
30/11/18 30/11/17 30/11/16 30/11/15 30/11/14 30/11/13 30/11/12 CAGR
Date 30/11/18 30/11/17 30/11/16 30/11/15 28/11/14 29/11/13 - -
Price 1.6500 1.9200 1.3500 2.0400 1.2600 1.8100 0.0000 -
P/RPS 0.64 0.84 0.65 1.16 0.77 1.17 0.00 -
  YoY % -23.81% 29.23% -43.97% 50.65% -34.19% 0.00% -
  Horiz. % 54.70% 71.79% 55.56% 99.15% 65.81% 100.00% -
P/EPS 18.28 27.76 42.17 75.69 51.87 27.28 0.00 -
  YoY % -34.15% -34.17% -44.29% 45.92% 90.14% 0.00% -
  Horiz. % 67.01% 101.76% 154.58% 277.46% 190.14% 100.00% -
EY 5.47 3.60 2.37 1.32 1.93 3.67 0.00 -
  YoY % 51.94% 51.90% 79.55% -31.61% -47.41% 0.00% -
  Horiz. % 149.05% 98.09% 64.58% 35.97% 52.59% 100.00% -
DY 6.06 3.13 2.22 0.00 0.00 0.00 0.00 -
  YoY % 93.61% 40.99% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 272.97% 140.99% 100.00% - - - -
P/NAPS 2.54 3.15 2.41 3.71 2.33 3.62 0.00 -
  YoY % -19.37% 30.71% -35.04% 59.23% -35.64% 0.00% -
  Horiz. % 70.17% 87.02% 66.57% 102.49% 64.36% 100.00% -
Price Multiplier on Announcement Date
30/11/18 30/11/17 30/11/16 30/11/15 30/11/14 30/11/13 30/11/12 CAGR
Date 24/01/19 23/01/18 24/01/17 27/01/16 27/01/15 28/01/14 - -
Price 1.6800 1.9000 1.3600 1.9000 1.1900 2.0800 0.0000 -
P/RPS 0.65 0.83 0.66 1.08 0.73 1.35 0.00 -
  YoY % -21.69% 25.76% -38.89% 47.95% -45.93% 0.00% -
  Horiz. % 48.15% 61.48% 48.89% 80.00% 54.07% 100.00% -
P/EPS 18.61 27.47 42.48 70.49 48.99 31.35 0.00 -
  YoY % -32.25% -35.33% -39.74% 43.89% 56.27% 0.00% -
  Horiz. % 59.36% 87.62% 135.50% 224.85% 156.27% 100.00% -
EY 5.37 3.64 2.35 1.42 2.04 3.19 0.00 -
  YoY % 47.53% 54.89% 65.49% -30.39% -36.05% 0.00% -
  Horiz. % 168.34% 114.11% 73.67% 44.51% 63.95% 100.00% -
DY 5.95 3.16 2.21 0.00 0.00 0.00 0.00 -
  YoY % 88.29% 42.99% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 269.23% 142.99% 100.00% - - - -
P/NAPS 2.58 3.11 2.43 3.45 2.20 4.16 0.00 -
  YoY % -17.04% 27.98% -29.57% 56.82% -47.12% 0.00% -
  Horiz. % 62.02% 74.76% 58.41% 82.93% 52.88% 100.00% -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

605  230  568 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 FOCUS 0.06-0.005 
 GOCEAN 0.0450.00 
 MTOUCHE 0.285+0.005 
 TANCO-WB 0.07+0.02 
 PERMAJU 0.1450.00 
 TANCO 0.145+0.01 
 MINDA 0.145+0.02 
 UCREST 0.30+0.005 
 TAWIN-OR 0.065-0.005 
 CAREPLS 2.41+0.05 

FEATURED POSTS

1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Chinese Sinopharm broke Western Pharmaceutical Industry’s monopoly - Koon Yew Yin Koon Yew Yin's Blog
2. World’s largest pig farm in China will 'produce' 2 million pigs per year - Koon Yew Yin Koon Yew Yin's Blog
3. OCK - The Unfaltering Tower OCK - The 5G Battle by Zyke42
4. China’s Sinovac shot found highly effective in real world study Good Articles to Share
5. TWO POWERFUL FACTORS WHY PALM OIL BULL RUN CAN LAST MUCH LONGER THIS ROUND, Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
6. FCPO FOR MAY 2021 NOW IS RM4,880 (TIME WHEN ALL GOES DOWN PALM OIL UP: SO BUY PALM OIL SHARES ON SALE, Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
7. The Competitive Edge of NEXGRAM (0096) in Vaccine Passport and Digital Facilitation Services: THE NEW GEM IN HEALTHCARE Nexgram (0096) - THE NEW GEM IN HEALTHCARE
8. When will the pandemic end? Out of the box
PARTNERS & BROKERS